UR9A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 5.4 EUR 0.93% Market Closed

Market Cap: €270.7m

	Clinuvel Pharmaceuticals Ltd F:UR9A	AU
	Bel Fuse Inc F:BF2B	US
	Absa Group Ltd F:AU61	ZA
	MTU Aero Engines AG F:MTX1	DE
M	Maple Leaf Foods Inc F:M1L	CA
A	AMP Ltd F:AMP	AU
	Page Industries Ltd BSE:532827	IN
	Nano One Materials Corp F:LBMB	CA
B	Bank Ozk F:BO8	US
I	Intellect Design Arena Ltd BSE:538835	IN
	ARC Resources Ltd TSX:ARX	CA

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

102% > 95%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

53%

Declining Operating Margin

60% > 45%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

38%

Declining Net Margin

37% > 34%

Exceptional Free Cash Flow Margin

42%

Strong 3Y Average Free Cash Flow Margin

39%

Declining Free Cash Flow Margin

59% > 42%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

110%

Declining ROIC

200% > 108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.